Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Hockerman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 10, 2010
MMP-13 selective isonipecotamide alpha-sulfone hydroxamatesStephen A Kolodziej, Susan L Hockerman, Gary A DeCrescenzo, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
MMP-13 selective α-sulfone hydroxamates: a survey of P1' heterocyclic amide isosteresThomas E Barta, Daniel P Becker, Louis J Bedell, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2010
Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamatesStephen A Kolodziej, Susan L Hockerman, Terri L Boehm, et al.
Journal of Medicinal Chemistry|August 3, 2010
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathyMarvin J Meyers, Graciela B Arhancet, Susan L Hockerman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|June 10, 2010
MMP-13 selective isonipecotamide alpha-sulfone hydroxamatesStephen A Kolodziej, Susan L Hockerman, Gary A DeCrescenzo, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
MMP-13 selective α-sulfone hydroxamates: a survey of P1' heterocyclic amide isosteresThomas E Barta, Daniel P Becker, Louis J Bedell, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2010
Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamatesStephen A Kolodziej, Susan L Hockerman, Terri L Boehm, et al.
Journal of Medicinal Chemistry|August 3, 2010
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathyMarvin J Meyers, Graciela B Arhancet, Susan L Hockerman, et al.
Pageof 1